Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study

Johan Sundström, Navdeep Tangri, Gijs VanPottelbergh et al.|The Lancet Regional Health - Europe|2022

Cited by 315